Stock RDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-07-16 pm EDT 		5-day change 1st Jan Change
78.47 USD -2.45% Intraday chart for Dr. Reddy's Laboratories Limited +1.02% +12.78%
Jul. 16 Asian Equities Traded in the US as American Depositary Receipts Move Modestly Higher in Tuesday Trading MT
Jul. 16 Indian Equities Achieve New Closing Highs on Tuesday, Led by Realty, FMCG Goods Stocks MT

Business Summary

Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:

- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;

- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;

- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.

Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).

Number of employees: 27,048

Sales per Business

INR in Million2023Weight2024Weight Delta
Global Generics
87.9 %
213,768 86.9 % 245,453 87.9 % +14.82%
Pharmaceutical Services and Active Ingredients
10.7 %
29,069 11.8 % 29,801 10.7 % +2.52%
Others
1.4 %
3,042 1.2 % 3,910 1.4 % +28.53%

Sales per region

INR in Million2023Weight2024Weight Delta
United States
48.6 %
106,683 43.4 % 135,565 48.6 % +27.07%
Others
26.1 %
67,469 27.4 % 72,825 26.1 % +7.94%
India
17.4 %
50,499 20.5 % 48,473 17.4 % -4.01%
Russia
8.0 %
21,228 8.6 % 22,301 8.0 % +5.05%

Managers

Managers TitleAgeSince
Erez Israeli CEO
 Chief Executive Officer 57 18-04-01
Parag Agarwal DFI
 Director of Finance/CFO - 20-11-01
Satish Kallam Reddy CHM
 Chairman 56 93-01-17
Gunupati Prasad CHM
 Chairman 63 86-04-07
B. Phanimitra CTO
 Chief Tech/Sci/R&D Officer - 23-07-31
K. Randhir Singh CMP
 Compliance Officer - 22-03-16
Jayanth Sridhar PRN
 Corporate Officer/Principal - -
Vivek Mittal LAW
 General Counsel - 21-04-30
Deepak Sapra PRN
 Corporate Officer/Principal - 02-12-31
Archana Bhaskar HRO
 Human Resources Officer 57 17-05-31

Members of the board

Members of the board TitleAgeSince
Gunupati Prasad CHM
 Chairman 63 86-04-07
Satish Kallam Reddy CHM
 Chairman 56 93-01-17
Kalpana Morparia BRD
 Director/Board Member 74 07-06-04
Shikha Sharma BRD
 Director/Board Member 64 19-01-30
Claudio Albrecht BRD
 Director/Board Member 64 23-05-09
Arun M. Kumar BRD
 Director/Board Member 72 22-07-31
Sanjiv Mehta BRD
 Director/Board Member 63 Dec. 28
Kodumudi P. Krishnan BRD
 Director/Board Member 64 22-01-06
Alpna Seth BRD
 Director/Board Member 60 23-09-18
Penny Wan BRD
 Director/Board Member - 22-01-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 166,829,701 117,879,796 ( 70.66 %) 289,791 ( 0.1737 %) 70.66 %

Shareholders

NameEquities%Valuation
Gunupati Prasad
11.52 %
19,219,184 11.52 % 1 476 M $
Satish Kallam Reddy
9.607 %
16,027,126 9.607 % 1 231 M $
Life Insurance Corporation of India (Investment Portfolio)
5.017 %
8,369,879 5.017 % 643 M $
Reddy Satish Kallam Family
3.311 %
5,523,677 3.311 % 424 M $
First Sentier Investors (Australia) IM Ltd.
2.319 %
3,869,125 2.319 % 297 M $
Prasad Gunupati Venkateswara Family
1.525 %
2,543,418 1.525 % 195 M $
SBI Funds Management Ltd.
1.416 %
2,361,643 1.416 % 181 M $
Mirae Asset Investment Managers (India) Pvt Ltd.
1.192 %
1,988,922 1.192 % 153 M $
GIC Pte Ltd. (Investment Management)
1.024 %
1,708,857 1.024 % 131 M $
HDFC Asset Management Co. Ltd. (Invt Mgmt)
0.9596 %
1,600,759 0.9596 % 123 M $
NameEquities%Valuation
RBC Dominion Securities, Inc.
1.316 %
2,195,817 1.316 % 167 M $
Robeco Alternative Investments
1.184 %
1,974,720 1.184 % 150 M $
Renaissance Technologies LLC
1.157 %
1,929,889 1.157 % 147 M $
BlackRock Advisors LLC
0.9541 %
1,591,727 0.9541 % 121 M $
Goldman Sachs Asset Management LP
0.9346 %
1,559,128 0.9346 % 119 M $
Aikya Investment Management Ltd.
0.7433 %
1,239,935 0.7433 % 94 M $
Vanguard Fiduciary Trust Co.
0.6108 %
1,019,011 0.6108 % 78 M $
Merrill Lynch International
0.5345 %
891,650 0.5345 % 68 M $
Morgan Stanley Capital Services LLC
0.5256 %
876,889 0.5256 % 67 M $
DFA Australia Ltd.
0.4749 %
792,304 0.4749 % 60 M $

Company contact information

Dr. Reddy's Laboratories Ltd.

Door No. 8-2-337 Road No. 3

500034, Hyderabad

+91 40 4900 2900

http://www.drreddys.com
address Dr. Reddy's Laboratories Limited(RDY)

Group companies

NameCategory and Sector
Dr. Reddy's Laboratories SA
Logo Dr. Reddy's Laboratories SA

Dr. Reddy's Laboratories SA

Pharmaceuticals: MajorHealth Technology

Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The company is based in Basel, Switzerland.

Pharmaceuticals: Major
Aurigene Discovery Technologies Ltd.
Logo Aurigene Discovery Technologies Ltd.

Aurigene Discovery Technologies Ltd.

BiotechnologyHealth Technology

Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India.

Biotechnology
Aurigene Pharmaceutical Services Ltd.
Logo Aurigene Pharmaceutical Services Ltd.

Aurigene Pharmaceutical Services Ltd.

BiotechnologyHealth Technology

Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India.

Biotechnology

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Dr. Reddy's Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,643 INR
Average target price
6,164 INR
Spread / Average Target
-7.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+61.53% 848B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.58% 627B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.66% 363B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.06% 318B
ABBVIE INC. Stock AbbVie Inc.
+9.18% 299B
ROCHE HOLDING AG Stock Roche Holding AG
+11.98% 234B
NOVARTIS AG Stock Novartis AG
+16.19% 225B
AMGEN INC. Stock Amgen Inc.
+15.67% 179B
PFIZER, INC. Stock Pfizer, Inc.
+2.47% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. RDY Stock
  5. Company Dr. Reddy's Laboratories Limited